EP3419593
ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
:
EP einkaleyfi: Þýðing ekki lögð inn:
2.12.2016:
23.3.2022:
16816810.2
:
1.12.2036
:
ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
2.12.2016
23.3.2022
:
Celgene Corporation:
86 Morris Avenue, Summit, NJ 07901, US
:
Les Laboratoires Servier:
50 rue Carnot, 92284 Suresnes Cedex, FR
:
AMATANGELO, Michael:
Madison, NJ 07940, US
:
HU, Xiaolan:
Skillman, NJ 08558, US
:
THAKURTA, Anjan:
Basking Ridge, NJ 07920, US
:
CHOE, Sung Eun:
Lexington, MA 02421, US
:
WU, Bin:
Belmont, MA 02478, US
:
201662300673 P:
26.2.2016:
US
:
US2016064615:
2.12.2016
:
A61K 31/365, A61K 31/404, A61K 31/437, A61K 31/44, A61K 31/444, A61K 31/4709, A61K 31/496, A61K 31/497, A61K 31/5025, A61K 31/53, A61K 31/5377, A61K 31/551, A61K 31/553, A61K 45/06, A61K 9/00, A61P 35/00, A61P 35/02, C07D 251/52, C07D 401/14, C07D 403/14